Total planned funding: $162,341,588
Allocations
Countries/Regions
India | $162,341,588 |
Organizational Types
Unknown | $70,823,050 |
NGO | $47,173,511 |
Own Agency | $26,668,527 |
University | $9,750,000 |
Multi-lateral Agency | $3,510,000 |
FBO | $2,700,000 |
Private Contractor | $900,000 |
Host Country Government Agency | $409,200 |
Other USG Agency | $407,300 |
Program Areas
Governance and Systems | $48,539,584 |
Prevention | $47,105,560 |
Care | $27,067,913 |
Management and Operations | $19,063,205 |
Testing | $10,822,961 |
Treatment | $9,742,365 |
Budget Codes
HVOP: Sexual Prevention: Other Sexual Prevention | $24,602,532 |
OHSS: Health Systems Strengthening | $22,290,993 |
HVMS: Management and Operations | $19,063,205 |
HVSI: Strategic Information | $18,831,941 |
HBHC: Care: Adult Care and Support | $18,351,849 |
HVCT: Testing: HIV Testing and Counseling | $10,822,961 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,549,446 |
HTXS: Treatment: Adult Treatment | $9,057,740 |
HLAB: Laboratory Infrastructure | $7,416,650 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,043,021 |
HVTB: Care: TB/HIV | $4,688,240 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,781,313 |
HKID: Care: Orphans and Vulnerable Children | $3,623,062 |
HMBL: Biomedical Prevention: Blood Safety | $2,129,248 |
PDTX: Treatment: Pediatric Treatment | $661,148 |
PDCS: Care: Pediatric Care and Support | $404,762 |
HTXD: Treatment: ARV Drugs | $23,477 |
Top Partner Programs
Not Available:
$69,775,561
Countries/Regions
USG Aggregated Agencies:
$18,173,374
Countries/Regions
FHI 360:
$18,088,228
Countries/Regions
Voluntary Health Services:
$9,030,000
Countries/Regions